A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
Clinical trial NCT06113731 · UNKNOWN
Trial details
- NCT number
- NCT06113731
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-10
- Primary completion
- 2023-10-30
- Enrollment
- 980
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.